Abbott says Absorb sales accounted for less than 1% of Abbott’s overall stent sales globally, including in India. In a statement posted on Friday on its website, the company said it is discontinuing all sizes of the Absorb bioresorbable vascular scaffold system, effective 14 September. According to Abbott spokesperson, Absorb sales accounted for less than 1% of Abbott’s overall stent sales globally, including in India. The revolutionary dis-solvable stent, Absorb, were priced at Rs1.9 lakh each before the cap. For larger vessels, the regulator has said that the bioresorbable stents may be used, but only in controlled settings.

Source: Mint September 09, 2017 09:22 UTC